Summary & Overview
HCPCS Q4356: Abiomend Membrane, Adjunctive Biologic Membrane
HCPCS Level II code Q4356 denotes the use of Abiomend membrane and Abiomend hydromembrane, reported per square centimeter as an add-on to a primary procedure. The code is used to capture the application of a biologic membrane product that augments wound closure or tissue repair in conjunction with a separate primary surgical or wound-care service. Nationally, accurate use of this add-on HCPCS code matters for clinical documentation, product utilization tracking, and consistent billing for adjunctive biologic materials across care settings.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for the product, typical sites of service where the code is used, common modifiers associated with the code, and guidance on what data are and are not available in the input. The publication summarizes benchmarks and policy touchpoints relevant to add-on biologic product coding, outlines typical billing scenarios, and highlights areas where payer-specific coverage criteria or coding guidance commonly apply. This national-level summary is intended for billing professionals, clinical coders, policy analysts, and practice managers seeking a clear reference on reporting HCPCS Level II code Q4356 for adjunctive membrane products.
Billing Code Overview
HCPCS Level II code Q4356 describes Abiomend membrane and abiomend hydromembrane, billed per square centimeter as an add-on, list separately in addition to primary procedure. This code represents a biologic wound or surgical membrane product applied adjunctively to a primary operative or wound-care procedure.
Service Type: Adjunctive biologic membrane product used in surgical or wound-care procedures
Typical Site of Service: Operative settings or wound-care locations where a primary procedure is performed, including hospital operating rooms, ambulatory surgical centers, and outpatient wound-care clinics.
Clinical & Coding Specifications
Clinical Context
A 58-year-old patient presents to an outpatient surgical clinic with a full-thickness soft tissue defect of the lower extremity after debridement of a chronic non-healing wound with exposed tendon and/or bone. The surgical team performs definitive wound bed preparation and applies a biologic barrier membrane product (Q4356 billed per square centimeter) as an adjunct to primary closure, grafting, or flap coverage. The workflow includes preoperative assessment, intraoperative measurement of membrane area in square centimeters for accurate Q4356 dosing and documentation, application of the membrane to the prepared wound bed to support tissue regeneration and fluid management, and placement of appropriate dressings or negative-pressure wound therapy. Postoperative documentation includes the membrane product name, square centimeters applied, the primary procedure CPT code (for closure, graft, or flap), wound bed condition, and follow-up wound care instructions.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier (default) | Use when no special reporting modifier applies and the add-on membrane is reported with the primary procedure. |